{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae 25 OH Vitamin D TOTAL Assay"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K112725",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071480"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG"
    ],
    "Summary Letter Date": "December 20, 2011",
    "Summary Letter Received Date": "December 22, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "25-hydroxyvitamin D",
        "hydroxylated vitamin D metabolites"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae Analyzer family"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Direct competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for LIAISON\u00ae 25 OH Vitamin D TOTAL Assay for quantitative determination of vitamin D metabolites in serum using CLIA on LIAISON analyzers",
    "Indications for Use Summary": "Quantitative determination of 25-hydroxyvitamin D and other hydroxylated vitamin D metabolites in human serum for assessment of vitamin D sufficiency in adults",
    "fda_folder": "Clinical Chemistry"
}